KM-003

N/A

Report date: 2022/11/25 18:08:37
NME

Base Information

Drug NameKM-003
Drug Alias NameP-552-02CF-552P-552KM-552KM-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsXerostomiaCystic FibrosisSjogren's Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesParion Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKainos Medicine IncParion Sciences Inc
Active IndicationsN/A
Inactive IndicationsXerostomiaCystic FibrosisSjogren's Syndrome

Other Information

ATC CodeN/A
Related LinksN/A